Chemotherapy vs. allogeneic transplantation as post molecular remission therapy in patients aged less than 60 years with Philadelphia-positive ALL

被引：8
|
作者：
Wang, Libing [1 ]
Du, Juan [2 ]
Huang, Aijie [1 ]
Tang, Gusheng [1 ]
Gong, Shenglan [1 ]
Cheng, Hui [1 ]
Zhang, Weiping [1 ]
Yang, Jianmin [1 ]
Wang, Jianmin [1 ]
Hu, Xiaoxia [1 ]
机构：
[1] Changhai Hosp, Inst Hematol, Dept Hematol, Shanghai 200433, Peoples R China
[2] Changzheng Hosp, Dept Hematol, Shanghai 200003, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / 01期
基金：
中国国家自然科学基金;
关键词：
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ADULT PATIENTS; IMATINIB; IMPACT; PLUS; MRD;
D O I：
10.1038/s41409-019-0514-4
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：245 / 248
页数：4
相关论文
共 50 条
  • [31] Long-term follow-up of Asian patients younger than 46 years with acute myeloid leukemia in first complete remission: comparison of allogeneic vs. autologous hematopoietic stem cell transplantation
    Loh, Yvonne Su Ming
    Koh, Liang Piu
    Tai, Bee Choo
    Hwang, William Ying Knee
    Linn, Yeh Ching
    Goh, Yeow Tee
    Tan, Patrick Huat Chye
    LEUKEMIA & LYMPHOMA, 2007, 48 (01) : 72 - 79
  • [32] ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS OLDER THAN 60 YEARS: A SURVEY FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
    Guepin, G. Roth
    Labopin, M.
    Ruggeri, A.
    Polge, E.
    Finke, J.
    Cornelissen, J.
    Fegueux, N.
    Stuhler, G.
    Rovira, M.
    Potter, M.
    Ganser, A.
    Veelken, H.
    Cahn, J. Y.
    Collin, M.
    Beguin, Y.
    Giebel, S.
    Nagler, A.
    Mohty, M.
    HAEMATOLOGICA, 2015, 100 : 14 - 14
  • [33] Sustained complete molecular response and low treatment related mortality after allogeneic haematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia patients previously treated with tyrosine kinase inhibitors
    de lavallade, H.
    Prebet, T.
    El Cheikh, J.
    Faucher, C.
    Vey, N.
    Charbonnier, A.
    Chabannon, C.
    Blaise, D.
    Furst, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S99 - S99
  • [34] Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy
    Sahasrabudhe, Kieran
    Huang, Ying
    Rebechi, Melanie
    Elder, Patrick
    Mims, Alice
    Wall, Sarah
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] 20-YEAR STEADY INCREASE IN POST-ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OUTCOMES FOR PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. A STUDY FROM THE EBMT ACUTE LEUKEMIA WORKING PARTY
    Bazarbachi, Ali
    Labopin, Myriam
    Abou Dalle, Iman
    Yakoub-Agha, Ibrahim
    de latour, Regis Peffault
    Schroeder, Thomas
    Blaise, Didier
    Poire, Xavier
    Balsat, Marie
    Salmenniemi, Urpu
    Kroeger, Nicolaus
    Kulagin, Alexander
    Wagner-Drouet, Eva Maria
    Wu, Depei
    Brissot, Eolia
    Nagler, Arnon
    Giebel, Sebastian
    Ciceri, Fabio
    Mohty, Mohammad
    BONE MARROW TRANSPLANTATION, 2024, 59 : 21 - 21
  • [36] Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
    Lussana, Federico
    Intermesoli, Tamara
    Gianni, Francesca
    Boschini, Cristina
    Masciulli, Arianna
    Spinelli, Orietta
    Oldani, Elena
    Tosi, Manuela
    Grassi, Anna
    Parolini, Margherita
    Audisio, Ernesta
    Cattaneo, Chiara
    Raimondi, Roberto
    Angelucci, Emanuele
    Cavattoni, Irene Maria
    Scattolin, Anna Maria
    Cortelezzi, Agostino
    Mannelli, Francesco
    Ciceri, Fabio
    Mattei, Daniele
    Borlenghi, Erika
    Terruzzi, Elisabetta
    Romani, Claudio
    Bassan, Renato
    Rambaldi, Alessandro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (11) : 1983 - 1987
  • [37] Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
    Kanamori, H.
    Mizuta, S.
    Kako, S.
    Kato, H.
    Nishiwaki, S.
    Imai, K.
    Shigematsu, A.
    Nakamae, H.
    Tanaka, M.
    Ikegame, K.
    Yujiri, T.
    Fukuda, T.
    Minagawa, K.
    Eto, T.
    Nagamura-Inoue, T.
    Morishima, Y.
    Suzuki, R.
    Sakamaki, H.
    Tanaka, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (12) : 1513 - 1518
  • [38] Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
    H Kanamori
    S Mizuta
    S Kako
    H Kato
    S Nishiwaki
    K Imai
    A Shigematsu
    H Nakamae
    M Tanaka
    K Ikegame
    T Yujiri
    T Fukuda
    K Minagawa
    T Eto
    T Nagamura-Inoue
    Y Morishima
    R Suzuki
    H Sakamaki
    J Tanaka
    Bone Marrow Transplantation, 2013, 48 : 1513 - 1518
  • [39] A randomized phase II study of single-agent imatinib versus chemotherapy therapy in elderly patients with Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) including analysis of resistance patterns
    Pfeifer, H
    Ottmann, OG
    Goekbuget, N
    Wunderle, L
    Brueck, P
    Giagounidis, A
    Stelijes, M
    Hochhaus, A
    Gschaidineier, H
    Hoelzer, D
    Wassmann, B
    BLOOD, 2005, 106 (11) : 519A - 519A
  • [40] NO ADVANTAGE OF ALLOGENEIC STEM CELL TRANSPLANTATION OVER MAINTENANCE CHEMOTHERAPY AS POST-REMISSION THERAPY IN ADULT PATIENTS WITH B-ACUTE LYMPHOBLASTIC LEUKEMIA IN OUR CENTRE
    Alpoim, M.
    Bras, G.
    Pinto, R.
    Carneiro, A.
    Prncipe, F.
    Guimaraes, J. E.
    HAEMATOLOGICA, 2015, 100 : 638 - 639
12345